SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.

ABSTRACT:

Background

Lebanon, a small country in the Middle East, remains severely affected by the COVID-19 pandemic. Seroprevalence surveys of anti-SARS-CoV-2 antibodies provide accurate estimates of SARS-CoV-2 infection and hence evaluate the extent of the pandemic. The present study aimed to evaluate the prevalence of SARS-CoV-2 antibodies in Lebanon and to compare the estimated cumulative number of COVID-19 cases with the officially registered number of laboratory-confirmed cases up to January 15, 2021.

Methods

A nationwide population-based serosurvey study was conducted in Lebanon between December 7, 2020, and January 15, 2021, before the initiation of the national vaccination program. The nCOVID-19 IgG & IgM point-of-care (POCT) rapid test was used to detect the presence of anti

SUBMITTER: Hoballah A 

PROVIDER: S-EPMC8744021 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature